Drug intelligence / Profile preview

Bronchoretard

Development stage
Phase 1
Lead developer
Astellas Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

**Bronchoretard** is a sustained-release brand formulation of theophylline, a methylxanthine derivative used as a bronchodilator for asthma, COPD, and other reversible airflow obstruction conditions. It relaxes bronchial smooth muscle, reduces airway responsiveness to stimuli, and provides prolonged therapeutic effects through extended-release capsules. The active ingredient, theophylline (sometimes as choline theophyllinate or oxtriphylline salt forms), inhibits phosphodiesterase enzymes, blocks adenosine receptors, and activates histone deacetylase to suppress inflammation.[2][3][11][12]

Brand names
Bronchoretard
Other names
Bronchoretard miteBronchoretard 100 juniorBronchoretard100 juniorBronchoretard-100 juniorBronchoretard 350Bronchoretard350Bronchoretard-350
02

Targets

ADORA2B (Adenosine A2B receptor)PDE3HDAC (HDAC family)PDE4 (Phosphodiesterase 4A1)

Beyond the preview

Go deeper on Bronchoretard.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bronchoretard.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call